17 February 2017 by Emilio Demetriou-Jones
Lefosse Advogados has helped Brazilian medical laboratory Instituto Hermes Pardini (IHP) raise 878 million reais (US$282 million) in an initial public offering.
Itaú BBA, Morgan Stanley, Bradesco BBI, Bank of America Merrill Lynch and JP Morgan were underwriters and turned to Davis Polk & Wardwell LLP in New York and São Paulo and Brazil’s Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados.
Several IHP shareholders enlisted counsel for the offering; Áurea Maria Pardini hired Freitas Ferraz Capuruço Riccio Advogados and Rolim de Mello Advogados; Victor Cavalcanti Pardini and Regina Pardini turned to Azevedo Sette Advogados and Tavernard Advogados, while Brazilian investment manager Gávea Investimentos also retained Lefosse.
Brazil’s IPO market was stagnant for much of 2016, until medical diagnostic company Alliar raised US$243 million in November.
The offering closed on 10 February.
Counsel to Instituto Hermes Pardini
Lefosse Advogados
Parters Rodrigo Junqueira, Maurício Paschoal, Bruno Carramaschi and Felipe Gibson and associate Douglas Ogata and Rafael Firmo in São Paulo
Counsel to Áurea Maria Pardini
Freitas Ferraz Capuruço Riccio Advogados
Partners Bernardo Freitas and Adriano Ferraz and associate João Luís Cesconi Lara in Belo Horizonte
Rolim de Mello Advogados
Partner Carlos de Mello and associate Natália Teixeira in São Paulo
Counsel to Victor Cavalcanti Pardini and Regina Pardini
Azevedo Sette Advogados
Partners Luiz Sette, Luis Ricardo Miraglia and Roberto Ribas Wilson in São Paulo
Tavernard Advogados
Partner Mário Tavernard Martins in São Paulo
Counsel to Itaú BBA, Morgan Stanley, Bradesco BBI, Bank of America Merril Lynch and JP Morgan
Davis Polk & Wardwell LLP
Partner Manuel Garciadiaz and associate Andrew Imber in New York and associate Elliot de Carvalho in São Paulo
Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados
Partners Jean Arakawa and Vanessa Fiusa and associates Fernando John Friedmann Junior and Felipe Rezende Kachan in São Paulo
http://latinlawyer.com/features/article/50984/lefosse-drives-us280-million-medical-lab-ipo/